Brad Kahl
0000-0003-0459-6609
3 papers found
Refreshing results…
A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma
Dose Finding Study of Ibrutinib and Venetoclax in Relapsed or Refractory Mantle Cell Lymphoma
Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions
Missing publications? Search for publications with a matching author name.